Moviprep

Polyethylene glycol (PEG), the active ingredient in Moviprep, is an osmotic laxative presented as a powder for reconstitution oral solution for oral use. It prepares the bowel for colonoscopy and radiologic examinations in adult patients.

GNH USA supplies Moviprep as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moviprep, an osmotic laxative used for bowel cleansing, is indicated for the following clinical situations: - Colonoscopy preparation: provides rapid and thorough evacuation of the colon to enable clear visualization. - Radiologic bowel examination: cleanses the colon before barium enema or CT colonography. - Endoscopic procedures: prepares the bowel for flexible sigmoidoscopy or other lower GI endoscopies.

Moviprep may cause a range of adverse reactions, most of which are related to its osmotic activity and electrolyte content.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal bloating: sensation of fullness or distension. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools during the cleansing process.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels requiring medical attention. - Dehydration: significant fluid loss leading to low blood pressure or dizziness. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

Before prescribing Moviprep, clinicians should consider several safety precautions to minimize risks. - Renal impairment: assess kidney function because fluid shifts may exacerbate renal insufficiency. - Cardiac disease: monitor patients with heart failure due to potential electrolyte disturbances. - Electrolyte disorders: correct existing hyponatremia or hypokalemia before use. - Gastrointestinal obstruction: avoid in patients with known or suspected bowel blockage. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Store at room temperature: keep below 25°C, retain in original packaging and protect from moisture.

Moviprep can interact with other medicines, primarily through its effect on fluid and electrolyte balance.

Major Interactions (Avoid): - Loop diuretics: may increase risk of dehydration and electrolyte loss. - Sodium polystyrene sulfonate: can exacerbate sodium shifts leading to severe imbalance.

Moderate Interactions (Monitor Closely): - Antihypertensives: monitor blood pressure as volume depletion may enhance hypotensive effect. - Lithium: watch serum lithium levels because changes in sodium can affect lithium clearance. - Oral iron supplements: may reduce efficacy of bowel cleansing if taken concurrently.